These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34176610)

  • 21. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study.
    Cho SH; Kim S; Lee YB; Jin SM; Hur KY; Kim G; Kim JH
    Front Endocrinol (Lausanne); 2023; 14():1165471. PubMed ID: 37255973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
    Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with the Enlite sensor in a multicenter pediatric study.
    Evans K; Richardson C; Landry A; Muileboom J; Cormack L; Lawson ML;
    Diabetes Educ; 2015 Feb; 41(1):31-7. PubMed ID: 25512220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-life utilization of real-time continuous glucose monitoring: the complete picture.
    Ramchandani N; Arya S; Ten S; Bhandari S
    J Diabetes Sci Technol; 2011 Jul; 5(4):860-70. PubMed ID: 21880227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 diabetes outcomes of children born in Israel of Eritrean asylum seekers.
    Elkon-Tamir E; Lebenthal Y; Laurian I; Dorfman A; Chorna E; Interator H; Israeli G; Rosen G; Eyal O; Oren A; Brener A
    Acta Diabetol; 2021 Feb; 58(2):145-152. PubMed ID: 32915299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
    Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
    Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study.
    Champakanath A; Akturk HK; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Care; 2022 Mar; 45(3):750-753. PubMed ID: 35018417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.
    Tsalikian E; Fox L; Weinzimer S; Buckingham B; White NH; Beck R; Kollman C; Xing D; Ruedy K;
    Pediatr Diabetes; 2012 Jun; 13(4):301-7. PubMed ID: 22151826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Lin R; Brown F; James S; Jones J; Ekinci E
    Diabet Med; 2021 May; 38(5):e14528. PubMed ID: 33496979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive Functions and Adherence to Continuous Glucose Monitoring in Children and Adolescents with Type 1 Diabetes.
    Farfel A; Liberman A; Yackobovitch-Gavan M; Phillip M; Nimri R
    Diabetes Technol Ther; 2020 Apr; 22(4):265-270. PubMed ID: 31789577
    [No Abstract]   [Full Text] [Related]  

  • 37. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Self-Efficacy, Transition Readiness and Diabetes Distress With Glycemic Control in Adolescents With Type 1 Diabetes Preparing to Transition to Adult Care.
    Alwadiy F; Mok E; Dasgupta K; Rahme E; Frei J; Nakhla M
    Can J Diabetes; 2021 Jul; 45(5):490-495. PubMed ID: 34176613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
    McGill DE; Volkening LK; Butler DA; Harrington KR; Katz ML; Laffel LM
    Diabetes Technol Ther; 2018 Jun; 20(6):434-439. PubMed ID: 29727245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motivational Interview to improve vascular health in Adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial.
    Pulkkinen MA; Tuomaala AK; Hero M; Gordin D; Sarkola T
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32723754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.